Metabolic syndrome-like components and prostate cancer risk: Results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Katharine N. Sourbeer, Lauren E. Howard, Gerald L. Andriole, Daniel M. Moreira, Ramiro Castro-Santamaria, Stephen J. Freedland, Adriana C. Vidal

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Metabolic syndrome-like components and prostate cancer risk: Results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry